The European Food Safety Authority (EFSA) has rejected probiotic dossiers from Canadian firm Lallemand Health Solutions (immunity) and Italian player Synbiotec (defecation) in a batch of opinions published today.
EFSA’s health claims panel has rejected 6 article 13.5 health claims for two digestion-focused probiotic submissions; cranberry and UTI; a potato extract and weight management; krill and menstrual discomfort; and fizzy water and GI response.
Significant effects, study products that matched those on-market and biologically plausible mechanisms were cited by the European Food Safety Authority (EFSA) as the major reasons why meal replacements won a rare article 13.1 positive opinion last week.
An article 14 disease risk reduction health claim linking mineral water consumption and a reduction of glycaemia has drawn a negative opinion from the European Food Safety Authority (EFSA).